Frecuencia de aberraciones moleculares en pacientes cubanos con leucemia mieloide aguda

Amor Vigil, Ana María; Hernández Miranda, Londy Lorena; Díaz Alonso, Carmen Alina; Ruiz Moleón, Vera; Fernández Martínez, Lesbia; Oliva Hernández, Ignacio; Garrote Santana, Heidys.
Rev. cuba. hematol. inmunol. hemoter ; 36(3): e1164, jul.-set. 2020. tab, graf
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1156440

Documentos relacionados

  1. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
  2. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia.
  3. Lifting the Differentiation Embargo.
  4. Aging and comprehensive molecular profiling in acute myeloid leukemia.
  5. Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
  6. Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
  7. Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia.
  8. Overlapping features of therapy-related and de novo NPM1-mutated AML.
  9. NPM1-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions.
  10. Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach.